Increased number of cell therapies for human well-being and growing use of PBMCs in toxicology research during the forecast period.
According to TechSci Research report, “Peripheral Blood Mononuclear Cells Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2017-2027”, the Global Peripheral Blood Mononuclear Cells market stood at USD 216.52 million in 2021 and is anticipated to grow with a CAGR of 9.38% in the forecast period, 2022-2027.
The major factors driving the growth of Peripheral Blood Mononuclear Cells Market include increase in number of cell therapies, growing R&D of Peripheral Blood Mononuclear Cells and growing usage of peripheral cells in toxicology research.
The peripheral blood mononuclear cells (PBMCs) are used to investigate the effect of food bio-actives on various immune cells. They have a round nucleus, consists of macrophages, dendritic cells, monocytes, and lymphocytes (T cells, B cells, and NK cells). However, these cells prevents the body by developing antibodies against antigens.
Browse over 168 market data Figures and 15 market data Tables spread through 318 Pages and an in-depth TOC on “Global Peripheral Blood Mononuclear Cells Market“.
The Global Peripheral Blood Mononuclear Cells Market is segmented into Product, Application, Technique, Source, Region, and Company. The market is segmented into Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits based on Product. In 2021, Cryopreserved or Frozen PBMC product segment holds the major revenue share i.e., 47.96%. Cryopreserved or Frozen PBMCs obtained from human or animal species and is used for long term storage. These cells can be utilized in human immunology. Over the projected period, this segment is also expected to increase at a healthy rate. The rate of increasing R&D and storage facilities leads to the growth of this segment in PBMCs market.
The market is classified into four categories based on the application: Immunology, Hematology, Infectious Disease, and Others include (Neurology, Cell & Gene Therapies, etc.). With a market share of 46.21% in 2021, the immunology is dominating the Global Peripheral Blood Mononuclear Cells Market. An increase in anti-bodies development of the immune system, leads to the growth of market.
Based on regional analysis, in terms of revenue share in 2021, North America dominated the global peripheral blood mononuclear cells market. This region’s expansion is being fueled by an increasing target population and a growing number of cell therapies. Europe accounted for the second-largest proportion, with significant increase predicted in the future years. During the predicted period, the Asia Pacific region is expected to grow strongly.
The leading companies operating in the Global Peripheral Blood Mononuclear Cells Market are:
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Biolegend Inc
- BioVision Inc
- ZEN-Bio Inc
- DAPCEL, Inc.
- Creative Bioarray
- iXCells Biotechnologies USA, LLC
- Miltenyi Biotec B.V. & CO. KG
- STEMCELL Technologies Inc.
- Precision Medicine Group, LLC.
- StemExpress, LLC
- RayBiotech Life, Inc.
- REPROCELL Inc.
- Cytologics LLC
- BioIVT LLC
- Biopredic International
- Cell Applications, Inc.
Customers can also request for 10% free customization on this report.
“Global Peripheral Blood Mononuclear Cells Market will see a robust growth during the forecast period of 2017-2027. The market for Peripheral Blood Mononuclear Cells is expected to develop due to rising research practices, cell-based therapies to either replace or regenerate human cells, tissues, or organs for normal functioning. The peripheral blood mononuclear cells market has also been fueled by advancements in technology, therapies, and treatments.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Peripheral Blood Mononuclear Cells Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2017-2027 Segmented By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Hematology, Infectious Disease, Others include ( Neurology, Cell & Gene Therapies, etc.), By Techniques (Density Gradient Centrifugation, Leukapheresis, Others (Fluorescence Activated Cell Sorting, Magnetic-Activated Cell Sorting, etc.), By Source (Human, Animals), By Region”, has evaluated the future growth potential of Global Peripheral Blood Mononuclear Cells Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Peripheral Blood Mononuclear Cells Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Connect with us on Twitter – https://twitter.com/TechSciResearch
Connect with us on LinkedIn – https://www.linkedin.com/company/techsci-research
